Colon/Rectum/Anus Cancer
A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers [ECOG 5202]
Principal Investigator:
Renee Jacobs, M.D.
Adventist La Grange Hospital
(708) 579-3418
Contact: Terri Crestani, MPH
A Randomized Phase III Trial of Oxaliplatin (OXAL) plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab after Curative Resection for Patients with Stage III Colon Cancer [NCCTG 0147]
Principal Investigator:
Renee Jacobs, M.D.
Adventist La Grange Hospital
(708) 579-3418
Contact: Terri Crestani, MPH
A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5 FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum [CALGB 80405]
Principal Investigator:
James Hannigan, M.D.
Adventist La Grange Hospital
(708) 579-3418
Contact: Terri Crestani, MPH
A Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab Followed by Surgery and Postoperative 5-FU, Leucovorisn, Oxaleplatin (FOLFOX) and Bevacizumab in Patients with Locally-Advanced Rectal Cancer [ECOG 3204]
Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.
Phase II Trial of Cetuximab plus Cisplatin, 5-Fluorouracil and Radiation in Immunocompetent Patients with Anal Carcinoma [ECOG 3205]
Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.
Intergroup Randomized Phase III Trial of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin versus Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation [ECOG 5204]
Principal Investigator:
Renee Jacobs, M.D.
Adventist La Grange Hospital
(708) 579-3418
Contact: Terri Crestani, MPH
Intergroup Randomized Phase III Trial of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin versus Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation [ECOG 5204]
Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.
A Clinical Trial Comparing Preoperative Radiation Therapy and Capecitabine with or without Oxaliplatin with Preoperative Radiation Therapy and Continuous Intravenous Infusion of 5-Fluorouracil with or without Oxaliplatin in the Treatment of Patients with Operable Carcinoma of the Rectum [NSABP R-04]
Principal Investigator:
Renee Jacobs, M.D.
Adventist La Grange Hospital
(708) 579-3418
Contact: Terri Crestani, MPH